Rifaximin

Details

Files

Generic Name:

Rifaximin

Project Status:

Complete

Therapeutic Area:

Hepatic encephalopathy

Manufacturer:

Salix Pharmaceuticals Inc.

Call for patient/clinician input open:

July 9, 2014

Brand Name:

Zaxine

Project Line:

Reimbursement Review

Project Number:

SR0388-000

Call for patient/clinician input closed:

August 28, 2014

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

Encephalopathy, Hepatic

Recommendation Type:

List with criteria/condition

Final Recommendation:

April 16, 2015

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Patient Group Input Submissions View PDF

Last Updated : August 5, 2014